196 related articles for article (PubMed ID: 9069302)
21. [Long-term results and prognostic factors of squamous cell carcinoma of the anal canal treated by irradiation].
Tournier-Rangeard L; Peiffert D; Lafond C; Mege A; Metayer Y; Marchesi V; Buchheit I; Uwer L; Conroy T; Kaminsky MC
Cancer Radiother; 2007 Jun; 11(4):169-77. PubMed ID: 17400501
[TBL] [Abstract][Full Text] [Related]
22. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
23. Patterns of recurrence in squamous cell carcinoma of the anal canal.
Luna-Pérez P; Fernández A; Labastida S; Lira-Puerto V; Vázquez-Curiel JA; Herrera L
Arch Med Res; 1995; 26(3):213-9. PubMed ID: 8580670
[TBL] [Abstract][Full Text] [Related]
24. Squamous cell carcinoma of the anal canal.
Mitchell SE; Mendenhall WM; Zlotecki RA; Carroll RR
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1007-13. PubMed ID: 11240241
[TBL] [Abstract][Full Text] [Related]
25. [Prognosis of epidermoid anal carcinoma regression after conservative treatment].
Vorob'ëv GI; Odariuk TS; Orlova LP; Nechushkin MI; Rybakov EG
Vopr Onkol; 2004; 50(6):663-7. PubMed ID: 15755059
[TBL] [Abstract][Full Text] [Related]
26. [The anal canal: 2 cycles of radiochemotherapy and boost brachytherapy].
Valentini V; Mantello G; Luzi S; Genovesi D; Smaniotto D; Mantini G; Coco C; Ratto C; Sofo L; Cellini N
Radiol Med; 1997 Apr; 93(4):451-6. PubMed ID: 9244925
[TBL] [Abstract][Full Text] [Related]
27. Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: ten years experience.
Sandhu AP; Symonds RP; Robertson AG; Reed NS; McNee SG; Paul J
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):575-81. PubMed ID: 9486607
[TBL] [Abstract][Full Text] [Related]
28. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy.
Weber DC; Kurtz JM; Allal AS
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):675-80. PubMed ID: 11395235
[TBL] [Abstract][Full Text] [Related]
29. [The prognostic factors following the simultaneous radiochemotherapy of anal canal carcinoma in a multicenter series of 139 patients].
Grabenbauer GG; Panzer M; Hültenschmidt B; Döker R; Huber K; Kuhne-Velte HJ; Hutter M; Rühl U; Budach V; Wendt T
Strahlenther Onkol; 1994 Jul; 170(7):391-9. PubMed ID: 8052938
[TBL] [Abstract][Full Text] [Related]
30. Inguinal lymph node recurrence in the untreated groin of patients with anal carcinoma.
Blinde SE; Schasfoort R; Mens JW; Verhoef C; Olofsen M; Nuyttens JJ
Dis Colon Rectum; 2014 May; 57(5):578-84. PubMed ID: 24819097
[TBL] [Abstract][Full Text] [Related]
31. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma.
Allal AS; Mermillod B; Roth AD; Marti MC; Kurtz JM
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1099-105. PubMed ID: 9392550
[TBL] [Abstract][Full Text] [Related]
32. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
Chauveinc L; Buthaud X; Falcou MC; Mosseri V; De la Rochefordière A; Pierga JY; Girodet J; Salmon RJ
Br J Cancer; 2003 Dec; 89(11):2057-61. PubMed ID: 14647138
[TBL] [Abstract][Full Text] [Related]
33. [Definitive treatment of anal canal carcinoma with radiotherapy: adverse impact of a pre-radiation resection. A retrospective study of 57 patients treated with curative intent].
Coquard R; Cenni JC; Artru P; Chalabreysse P; Queneau PE; Taieb S; Alessio A; Lledo G
Cancer Radiother; 2009 Dec; 13(8):715-20. PubMed ID: 19854092
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
[TBL] [Abstract][Full Text] [Related]
35. Chemoradiation for adenocarcinoma of the anus.
Papagikos M; Crane CH; Skibber J; Janjan NA; Feig B; Rodriguez-Bigas MA; Hung A; Wolff RA; Delclos M; Lin E; Cleary K
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):669-78. PubMed ID: 12573754
[TBL] [Abstract][Full Text] [Related]
36. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients.
Doci R; Zucali R; La Monica G; Meroni E; Kenda R; Eboli M; Lozza L
J Clin Oncol; 1996 Dec; 14(12):3121-5. PubMed ID: 8955657
[TBL] [Abstract][Full Text] [Related]
37. [External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients].
Dubois JB; Azria D; Ychou M
Bull Cancer; 2003 Dec; 90(12):1107-10. PubMed ID: 14715430
[TBL] [Abstract][Full Text] [Related]
38. Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin. Series of 57 patients.
Papillon J; Chassard JL
Dis Colon Rectum; 1992 May; 35(5):422-9. PubMed ID: 1568392
[TBL] [Abstract][Full Text] [Related]
39. Carcinoma of the anal canal.
Myerson RJ; Shapiro SJ; Lacey D; Lopez M; Birnbaum E; Fleshman J; Fry R; Kodner I
Am J Clin Oncol; 1995 Feb; 18(1):32-9. PubMed ID: 7847256
[TBL] [Abstract][Full Text] [Related]
40. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.
Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
